What Is Polypharmacy in Personal Injury Cases?

James Wong — Founder & Pharmacist, LienScripts | April 18, 2024 | 7 min read

Polypharmacy — the use of multiple medications simultaneously — is common in serious PI cases where patients manage complex, overlapping injury-related conditions. Understanding polypharmacy helps attorneys evaluate pharmacy lien balances, explain medication complexity to adjusters and juries, and anticipate defense challenges to multi-drug treatment regimens.

This post is for informational purposes only and does not constitute legal advice.

Multiple Medications, One Injured Patient

In clinical medicine, polypharmacy describes the concurrent use of five or more medications by a single patient. In personal injury cases involving serious or catastrophic injuries, polypharmacy is not unusual — it is often the expected clinical picture.

A patient who sustains a severe spinal injury in a motor vehicle accident may be simultaneously managed with opioid pain medications, muscle relaxants, neuropathic pain agents, anti-inflammatory drugs, sleep aids, antidepressants, and proton pump inhibitors (to protect against GI side effects of other medications). Each of these medications addresses a distinct clinical problem created by the injury. Together, they represent what is clinically called a polypharmacy regimen.

Understanding polypharmacy is important for PI attorneys because:

• It drives pharmacy lien balances higher and faster than single-drug cases
• It is more complex to explain to adjusters and at trial
• Defense counsel will challenge each drug's necessity individually
• The clinical rationale connecting each medication to the injury must be clearly documented

[!KEY] Polypharmacy — five or more concurrent medications — is expected in serious PI cases with complex injuries, and a MERIT report documenting each drug's clinical indication is essential to defending the lien balance against medication-by-medication challenges.

Why Polypharmacy Is Common in PI

Serious personal injury cases produce complex, multi-system clinical presentations:

Pain management. Acute and chronic pain from musculoskeletal injuries, nerve damage, or post-surgical recovery typically requires more than one medication. A combination of opioid analgesics, non-opioid analgesics (NSAIDs, acetaminophen), and adjuvant agents (gabapentin, duloxetine) is standard in pain medicine practice.

Neurological and neuropsychiatric sequelae. Traumatic brain injury (TBI), PTSD, anxiety, and depression are common following serious accidents. These conditions require their own medications, often in combination with the physical pain management regimen.

Post-traumatic migraine. A common sequela of TBI and whiplash injuries, post-traumatic migraine may require acute treatments (triptans, CGRP receptor antagonists), preventive agents (topiramate, amitriptyline, beta-blockers), and rescue medications.

Sleep disorders. Chronic pain and neurological injury commonly disrupt sleep. Sleep aids — from melatonin to trazodone to non-benzodiazepine hypnotics — are frequently added to manage sleep-related functional impairment.

GI protection. Many pain medications and anti-inflammatory drugs require co-administration of gastroprotective agents (proton pump inhibitors, H2 blockers) to prevent GI injury from the primary medications themselves.

Comorbidity management. Patients with pre-existing conditions that are worsened by the injury — such as diabetes, hypertension, or anxiety that is exacerbated by chronic pain — may require ongoing medications for these conditions.

Polypharmacy and the Pharmacy Lien Balance

In pharmacy lien cases, polypharmacy directly affects the lien balance. A patient on a 7-medication regimen for 18 months will accumulate a substantially larger lien balance than a patient on a single medication for 6 months.

For PI attorneys reviewing an LSR (Lien Summary Report), a multi-medication regimen may initially appear surprising. The LSR shows the total balance — the MERIT report explains why each medication was prescribed.

The MERIT report from LienScripts is particularly valuable in polypharmacy cases because it provides:

• The clinical indication for each medication (which injury-related condition it treats)
• The prescribing physician for each medication
• The treatment timeline (documenting duration of each medication's use)
• The clinical outcomes and adjustments to the regimen over time

This documentation is the foundation for defending the pharmacy lien balance against challenges to individual medications.

How Defense Counsel Attacks Polypharmacy Lien Balances

In polypharmacy cases, defense counsel and insurance adjusters commonly raise these challenges:

"The patient was over-medicated." Challenge the clinical necessity of multiple simultaneous medications, suggesting the treating physician was not practicing evidence-based medicine.

"Not all of these medications are related to this injury." Isolate individual medications and argue they treat pre-existing conditions, not accident-caused injuries.

"Generic alternatives would have cost far less." Argue the brand-name or specialty medications in the regimen should be valued at generic equivalents.

"Some of these medications should have been covered by health insurance." Argue the lien should be reduced because insurance would have covered certain drugs.

Each of these challenges is answered by the clinical documentation in the MERIT report, the prescribing physician's records, and — when needed — expert testimony from a clinical pharmacist or treating physician.

[!TIP] For Attorneys: When the LSR shows a large multi-drug lien balance, present the MERIT report alongside it — the MERIT breaks down each medication's injury-related indication, making the total balance understandable and difficult for adjusters to attack piecemeal.

Polypharmacy and Drug-Drug Interactions

[!KEY] When a physician adds or adjusts medications in response to drug-drug interaction concerns, those clinical decisions — documented in prescriber notes and the pharmacy record — show active, individualized oversight that counters the defense argument that a multi-drug regimen reflects over-treatment rather than medical necessity.

A clinically important aspect of polypharmacy is the risk of drug-drug interactions — the potential for multiple medications to interact in ways that affect efficacy or safety. In serious PI cases, managing drug-drug interactions is one of the reasons experienced prescribers — particularly pain management physicians — carefully coordinate the patient's full medication regimen.

For attorneys, drug-drug interaction documentation in the patient's medical record can actually support the polypharmacy regimen: it shows that the treating physician was aware of the multiple medications, evaluated for interactions, and made informed clinical decisions about each addition to the regimen.

Key Takeaway

[!KEY] Each medication in a polypharmacy regimen should trace back to a specific ICD-coded diagnosis from the treating physician — if a medication cannot be linked to an accident-related diagnosis, it does not belong on the pharmacy lien and its inclusion will invite the defense challenges most likely to reduce the lien balance at settlement.

Polypharmacy — the concurrent use of multiple medications — is a common feature of serious PI cases with complex injury presentations. It drives pharmacy lien balances higher, requires careful documentation to defend, and will be challenged by defense counsel on a medication-by-medication basis. A MERIT report from LienScripts that explains each medication's clinical rationale is the essential tool for supporting a polypharmacy-heavy pharmacy lien in settlement negotiations and at trial.